COVID-19 antibodies on trial

With the first readouts of trials of antibodies against COVID-19 appearing and others coming thick and fast, Nature Biotechnology asked a group of experts to comment on the challenges and timelines for these products.

Detalles Bibliográficos
Autor principal: DeFrancesco, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2020
Materias:
Q&A
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576980/
https://www.ncbi.nlm.nih.gov/pubmed/33087898
http://dx.doi.org/10.1038/s41587-020-0732-8
_version_ 1783598120797470720
author DeFrancesco, Laura
author_facet DeFrancesco, Laura
author_sort DeFrancesco, Laura
collection PubMed
description With the first readouts of trials of antibodies against COVID-19 appearing and others coming thick and fast, Nature Biotechnology asked a group of experts to comment on the challenges and timelines for these products.
format Online
Article
Text
id pubmed-7576980
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group US
record_format MEDLINE/PubMed
spelling pubmed-75769802020-10-22 COVID-19 antibodies on trial DeFrancesco, Laura Nat Biotechnol Q&A With the first readouts of trials of antibodies against COVID-19 appearing and others coming thick and fast, Nature Biotechnology asked a group of experts to comment on the challenges and timelines for these products. Nature Publishing Group US 2020-10-21 2020 /pmc/articles/PMC7576980/ /pubmed/33087898 http://dx.doi.org/10.1038/s41587-020-0732-8 Text en © Springer Nature America, Inc. 2020, corrected publication 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Q&A
DeFrancesco, Laura
COVID-19 antibodies on trial
title COVID-19 antibodies on trial
title_full COVID-19 antibodies on trial
title_fullStr COVID-19 antibodies on trial
title_full_unstemmed COVID-19 antibodies on trial
title_short COVID-19 antibodies on trial
title_sort covid-19 antibodies on trial
topic Q&A
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576980/
https://www.ncbi.nlm.nih.gov/pubmed/33087898
http://dx.doi.org/10.1038/s41587-020-0732-8
work_keys_str_mv AT defrancescolaura covid19antibodiesontrial

Ejemplares similares